Immuneering (NASDAQ:IMRX) Announces Earnings Results, Misses Expectations By $0.03 EPS
Immuneering (NASDAQ:IMRX – Get Rating) announced its earnings results on Thursday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.03), MarketWatch Earnings reports. Shares of NASDAQ IMRX opened at $6.49 on Friday. The stock has a 50 day moving average of $10.35 and a […]